We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

122 hedge funds and large institutions have $586M invested in Array Biopharma Inc in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

36% more capital invested

Capital invested by funds: $431M → $586M (+$155M)

12% more call options, than puts

Call options by funds: $4.84M | Put options by funds: $4.32M

9% more funds holding

Funds holding: 112 → 122 (+10)

9% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
122
Holders Change
+10
Holders Change %
+8.93%
% of All Funds
3.25%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
21
Increased
38
Reduced
35
Closed
9
Calls
$4.84M
Puts
$4.32M
Net Calls
+$517K
Net Calls Change
+$1.24M

Top Buyers

1
RG
Redmile Group
California
+$13.9M
2
First Manhattan
First Manhattan
New York
+$5.14M
3
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$3.96M
4
Axa
Axa
France
+$3.38M
5
O
OrbiMed
New York
+$3.34M

Top Sellers

1
BI
BVF Inc
California
-$8.32M
2
QF
QVT Financial
New York
-$8.03M
3
State Street
State Street
Massachusetts
-$5.9M
4
KIA
Kopp Investment Advisors
Minnesota
-$5.56M
5
AC
Apex Capital
California
-$4.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
26
Point72 Asset Management
Connecticut
$4.27M -$2.06M -522,000 -37%
Axa
27
Axa
France
$4.04M +$3.38M +854,606 New
CNB
28
City National Bank
California
$3.52M +$223K +56,464 +8%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$3.29M +$454K +114,894 +20%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.28M +$18K +4,544 +0.7%
KCM
31
Kennedy Capital Management
Missouri
$3.14M +$2.62M +663,662 New
PAM
32
Panagora Asset Management
Massachusetts
$2.94M +$126K +31,739 +5%
Principal Financial Group
33
Principal Financial Group
Iowa
$2.89M +$6.76K +1,710 +0.3%
KIA
34
Kopp Investment Advisors
Minnesota
$2.84M -$5.56M -1,405,353 -70%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$2.73M +$1.44M +363,333 +170%
RPAM
36
Rhenman & Partners Asset Management
Sweden
$2.58M +$656K +165,801 +44%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$2.49M – – –
TCIM
38
TIAA CREF Investment Management
New York
$2.19M -$51.1K -12,909 -3%
BG
39
BlackRock Group
United Kingdom
$2.1M +$31.3K +7,926 +2%
BIM
40
BlackRock Investment Management
Delaware
$1.76M -$28K -7,074 -2%
Two Sigma Investments
41
Two Sigma Investments
New York
$1.71M +$1.43M +362,119 New
QF
42
QVT Financial
New York
$1.71M -$8.03M -2,029,478 -85%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$1.68M +$1.4M +355,069 New
Charles Schwab
44
Charles Schwab
California
$1.64M +$29.9K +7,564 +2%
TD Asset Management
45
TD Asset Management
Ontario, Canada
$1.61M +$49K +12,400 +4%
CGT
46
Capital Guardian Trust
California
$1.42M -$534K -135,000 -31%
BlackRock
47
BlackRock
New York
$1.38M – – –
CS
48
Credit Suisse
Switzerland
$1.26M +$717K +181,330 +211%
State of New Jersey Common Pension Fund D
49
State of New Jersey Common Pension Fund D
New Jersey
$1.25M – – –
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$1.1M +$3.93K +994 +0.4%
1
2
3 4 5

ARRY Hedge Fund Activity: Q4 2014 in Review

122 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q4 2014, worth a combined $586M — up 36% from $431M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ARRY positions and 9 closed out — a net gain of 12 holders — while 38 added to existing stakes and 35 trimmed.

The largest buyer was Redmile Group, adding an estimated $13.9M. The largest seller was BVF Inc, cutting an estimated $8.32M.

  • 122 institutional investors held Array Biopharma Inc (ARRY) as of Q4 2014, up from 112 in Q3 2014.
  • Funds reported $586M of Array Biopharma Inc stock for Q4 2014, up 36% quarter-over-quarter.
  • 21 funds opened new Array Biopharma Inc positions in Q4 2014 and 9 closed out, a net change of +12 holders.
  • The largest Array Biopharma Inc buyer in Q4 2014 was Redmile Group, an estimated $13.9M added.
  • The largest Array Biopharma Inc seller in Q4 2014 was BVF Inc, an estimated $8.32M sold.

Based on aggregated 13F filings for Q4 2014.